Evidence map›Paper›PMID 39636110›Full record

ArticleJournal of virology2025

Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model.

Huibin Lv, Qi Wen Teo, Chang-Chun D Lee, Weiwen Liang, Danbi Choi, Kevin J Mao, Madison R Ardagh, Akshita B Gopal, Arjun Mehta, Matt Szlembarski and 4 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Huibin LvCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.ORCID 0000-0003-2218-0076
Qi Wen TeoCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Chang-Chun D LeeDepartment of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, California, USA.
Weiwen LiangHKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Danbi ChoiDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Kevin J MaoDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Madison R ArdaghDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Akshita B GopalDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Arjun MehtaDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Matt SzlembarskiDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Roberto BruzzoneHKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Ian A WilsonDepartment of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, California, USA.
Nicholas C WuCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.ORCID 0000-0002-9078-6697
Chris K P MokThe Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.ORCID 0000-0002-0525-6772

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00015 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HENSLEY, SCOTT · 2021 to 2025
$50.7M
Gates Foundation INV-004923NIAID NIH HHS 75N93021C00015
6 · The paper itself

Abstract

Understanding how immune history influences influenza immunity is essential for developing effective vaccines and therapeutic strategies. This study examines the antigenic imprinting of influenza hemagglutinin (HA) and neuraminidase (NA) using a mouse model with sequential infections by H1N1 virus strains exhibiting substantial antigenic differences in HA. In our pre-2009 influenza infection model, we observed that mice with more extensive infection histories produced higher levels of functional NA-inhibiting antibodies (NAI). However, following further infection with the 2009 pandemic H1N1 strain, these mice demonstrated a reduced NAI to the challenged virus. Interestingly, prior exposure to older strains resulted in a lower HA antibody response (neutralization and HAI) to the challenged virus in both pre- and post-2009 scenarios, potentially due to faster viral clearance facilitated by immune memory recall. Overall, our findings reveal distinct trajectories in HA and NA immune responses, suggesting that immune imprinting can differentially impact these proteins based on the extent of antigenic variation in influenza viruses. IMPORTANCE: Influenza viruses continue to pose a significant threat to human health, with vaccine effectiveness remaining a persistent challenge. Individual immune history is a crucial factor that can influence antibody responses to subsequent influenza exposures. While many studies have explored how pre-existing antibodies shape the induction of anti-HA antibodies following influenza virus infections or vaccinations, the impact on anti-NA antibodies has been less extensively studied. Using a mouse model, our study demonstrates that within pre-2009 H1N1 strains, an extensive immune history negatively impacted anti-HA antibody responses but enhanced anti-NA antibody responses. However, in response to the 2009 pandemic H1N1 strain, which experienced an antigenic shift, both anti-HA and anti-NA antibody responses were hindered by antibodies from prior pre-2009 H1N1 virus infections. These findings provide important insights into how antigenic imprinting affects both anti-HA and anti-NA antibody responses and underscore the need to consider immune history in developing more effective influenza vaccination strategies.

Indexed as

Antigens, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza A Virus, H1N1 SubtypeNeuraminidaseOrthomyxoviridae InfectionsAnimalsAntibodies, NeutralizingAntibodies, ViralAntigenic VariationDisease Models, AnimalFemaleHumansInfluenza, HumanInfluenza VaccinesMiceMice, Inbred BALB CAntibodies, NeutralizingAntibodies, ViralAntigens, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesNeuraminidaseantigenic imprintinghemagglutinin (HA)immune historyneuraminidase (NA)

Identifiers

PMID39636110
PMCPMC11784018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.